发明名称 |
Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized byabnormal cell proliferation, diarrhe and scours |
摘要 |
The present invention provides substituted 3,3-diphenyl indanone, indane and indole compounds, as well as analogues thereof which are specific, potent and safe inhibitors of the Ca<2+>-activated potassium channel (Gardos channel) of erythrocytes, of mammalian cell proliferation and/or of secretagogue-stimulated transepithelial electrogenic chloride secretion in intestinal cells. The compounds can be used to reduce sickle erytrocyte dehydration and/or delay the occurrence of erythrocyte sickling or deformation in situ as a therapeutic approach towards the treatment or prevention of sickle cell disease. The compounds can also be used to inhibit mamalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation. Furthermore, the compounds can also be used to inhibit chloride secretion in intestinal cells as a therapeutic approach towards the treatment of diarrhea and scours. |
申请公布号 |
AU1598899(A) |
申请公布日期 |
1999.06.15 |
申请号 |
AU19990015988 |
申请日期 |
1998.11.20 |
申请人 |
CHILDREN'S MEDICAL CENTER CORPORATION;PRESIDENT AND FELLOWS OF HARVARD COLLEGE;ION PHARMACEUTICALS, INC. |
发明人 |
CARLO BRUGNARA;JOSE HALPERIN;EMILE M. BELLOT JR.;MARK FROIMOWITZ;RICHARD JOHN LOMBARDY;JOHN J. CLIFFORD;YING-DUO GAO;REEM M. HAIDAR;EUGENE W. KELLEHER;FALGUNI M. KHER;ADEL M. MOUSSA;YESH P SACHDEVA;MINGHUA SUN;HEATHER N. TAFT;WAYNE I. LENCER;SETH ALPER |
分类号 |
C07D317/20;A61K31/045;A61K31/075;A61K31/12;A61K31/122;A61K31/15;A61K31/165;A61K31/216;A61K31/222;A61K31/235;A61K31/277;A61K31/336;A61K31/357;A61K31/403;A61K31/404;A61K35/20;A61P1/00;A61P9/00;A61P9/10;A61P13/12;A61P17/00;A61P29/00;A61P37/02;A61P43/00;C07D209/14 |
主分类号 |
C07D317/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|